0000000001182828

AUTHOR

Rossella Spataro

0000-0002-8910-3131

showing 68 related works from this author

Sleep–wake problems in patients with amyotrophic lateral sclerosis: implications for patient management

2012

SUMMARY Sleep–wake problems are frequent, although unrecognized, complications of amyotrophic lateral sclerosis (ALS). Sleep disorders such as insomnia, sleep-disordered breathing and restless legs syndrome have all been reported in patients with ALS, despite the limited number of studies and the small populations investigated so far. Sleep disturbances gradually worsen with disease progression, suggesting a relationship between the severity of disease and the neurodegenerative process. However, poor sleep can also be a consequence of several disturbances such as anxiety, depression, pain, choking, sialorrhea, fasciculations, cramps, nocturia and the inability to get comfortable and move f…

medicine.medical_specialtybusiness.industrymedicine.diseasePhysical medicine and rehabilitationExcessive daytime somnolencemedicineInsomniaNocturiaAnxietyNeurology (clinical)Restless legs syndromemedicine.symptomAmyotrophic lateral sclerosisChokingbusinessDepression (differential diagnoses)Neurodegenerative Disease Management
researchProduct

Effects of a Vibro-Tactile P300 Based Brain-Computer Interface on the Coma Recovery Scale-Revised in Patients With Disorders of Consciousness

2020

Persons diagnosed with disorders of consciousness (DOC) typically suffer from motor and cognitive disabilities. Recent research has shown that non-invasive brain-computer interface (BCI) technology could help assess these patients’ cognitive functions and command following abilities. 20 DOC patients participated in the study and performed 10 vibro-tactile P300 BCI sessions over 10 days with 8–12 runs each day. Vibrotactile tactors were placed on the each patient’s left and right wrists and one foot. Patients were instructed, via earbuds, to concentrate and silently count vibrotactile pulses on either their left or right wrist that presented a target stimulus and to ignore …

medicine.medical_specialtydisorders of consciousneAudiologydisorders of consciousness BCI performance tactile stimulation P300 event-related potential CRS-R050105 experimental psychologylcsh:RC321-57103 medical and health sciencesCognitive disabilities0302 clinical medicineMedicine0501 psychology and cognitive sciencesIn patientPatient grouplcsh:Neurosciences. Biological psychiatry. Neuropsychiatrydisorders of consciousnessBrain–computer interfaceOriginal ResearchSensory stimulation therapyP300 event-related potentialbusiness.industryCRS-RGeneral Neuroscience05 social sciencesRepeated measures designGrand averageCognitionBCI performancetactile stimulationbusiness030217 neurology & neurosurgeryNeuroscience
researchProduct

Intraspinal stem cell transplantation for amyotrophic lateral sclerosis: Ready for efficacy clinical trials?

2016

Intraspinal stem cell (SC) transplantation represents a new therapeutic approach for amyotrophic lateral sclerosis (ALS) clinical trials. There are considerable difficulties in designing future efficacy trials, some related to the field of ALS and some that are specific to SCs or the mode of delivery. In October 2015, the most controversial points on SC transplantation were addressed during an international workshop intended to bring together international SC and ALS researchers in a public discussion on a topic for which expertise is limited. During the meeting, a discussion was started on the basic structure of the ideal clinical trial testing the efficacy and safety of SC transplantation…

0301 basic medicineCancer ResearchCell- and Tissue-Based Therapy0302 clinical medicinePublic discussionNeural Stem CellsImmunology and AllergyNeural Stem CellALS; clinical trials; stem cells; transplantation; Immunology and Allergy; Immunology; Oncology; Genetics (clinical); Cell Biology; Cancer Research; TransplantationAmyotrophic lateral sclerosisGenetics (clinical)clinical trialMiddle AgedOncologyStem cellSafetyHumanAdultmedicine.medical_specialtyConsensusAdolescentImmunologyConsensu03 medical and health sciencesTherapeutic approachYoung AdultClinical Trials Phase II as Topicstem cellsmedicineHumansIntensive care medicineAgedclinical trialsTransplantationbusiness.industryAmyotrophic Lateral SclerosisBIO/13 - BIOLOGIA APPLICATACell Biologymedicine.diseasestem cellClinical trialTransplantation030104 developmental biologyClinical Trials Phase III as TopicImmunologyALSbusiness030217 neurology & neurosurgeryAmyotrophic Lateral SclerosiStem Cell TransplantationCytotherapy
researchProduct

Complete locked-in and locked-in patients: Command following assessment and communication with vibro-tactile P300 and motor imagery brain-computer in…

2017

Many patients with locked-in syndrome (LIS) or complete locked-in syndrome (CLIS) also need brain-computer interface (BCI) platforms that do not rely on visual stimuli and are easy to use. We investigate command following and communication functions of mindBEAGLE with 9 LIS, 3 CLIS patients and three healthy controls. This tests were done with vibro-tactile stimulation with 2 or 3 stimulators (VT2 and VT3 mode) and with motor imagery (MI) paradigms. In VT2 the stimulators are fixed on the left and right wrist and the participant has the task to count the stimuli on the target hand in order to elicit a P300 response. In VT3 mode an additional stimulator is placed as a distractor on the shoul…

0301 basic medicinemedicine.medical_specialtyVisual perceptionComputer scienceInterface (computing)ElectroencephalographyAudiologyTask (project management)lcsh:RC321-57103 medical and health sciences0302 clinical medicineMode (computer interface)Motor imageryMotor imagerymedicineIn patientVibro-tactileBCIlcsh:Neurosciences. Biological psychiatry. NeuropsychiatrySimulationBrain–computer interfaceOriginal Researchmedicine.diagnostic_testGeneral NeuroscienceCommunicationEP030104 developmental biologyALS030217 neurology & neurosurgeryNeuroscience
researchProduct

THORACIC SYRINGOMYELIA IN A PATIENT WITH AMYOTROPHIC LATERAL SCLEROSIS

2015

We report a patient with bulba r - onset, clinically defined, sporadic amyotrophic lateral sclerosis bearing an isolated syringomyelia of the lower thoracic portion of the spinal cord. This is a very unusual association between two rare and progressive disorders, both affecting the spinal motoneurons. Syringomyelia might have acted as a phenotypic modifier in this ALS patient.

Community and Home Caremedicine.medical_specialtybusiness.industrymedicine.diseasePhenotypic modifierSpinal cordSurgerymedicine.anatomical_structureALS syringomyelia case reportmedicineSettore MED/26 - NeurologiaAmyotrophic lateral sclerosisbusinessSyringomyelia
researchProduct

Editorial: Breakthrough BCI Applications in Medicine

2020

medicine.diagnostic_testComputer scienceGeneral NeuroscienceSpeech recognitionElectroencephalographyclinical applicationslcsh:RC321-571EditorialMotor imagerymotor imagerymedicineEEGBCIP300lcsh:Neurosciences. Biological psychiatry. NeuropsychiatryNeuroscienceBrain–computer interfaceFrontiers in Neuroscience
researchProduct

Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination

2022

Adverse events occurring after SARS-CoV-2 vaccination have been reported and are the subject of ongoing research. We present the case of a young woman with fully reversible radiculomyelitis, which happened after the first dose of the ChAdOx1 nCOVID-19 vaccine. A previously healthy woman in her 20s presented with a subacute onset of legs’ weakness and sensory disturbances, urinary dysfunction and cramping pain after receiving the first dose of the ChAdOx1 nCoV-19 vaccine. A diagnostic workup led to the diagnosis of inflammatory radiculomyelitis. Her clinical status improved, with complete recovery after a few months. The case described a reversible radiculomyelitis associated with the ChAdOx…

COVID-19 myeloradiculoneuritis case reportCOVID-19 VaccinesSARS-CoV-2ChAdOx1 nCoV-19VaccinationCOVID-19HumansFemaleViral VaccinesSettore MED/26 - NeurologiaGeneral Medicine
researchProduct

Performance Differences Using a Vibro-Tactile P300 BCI in LIS-Patients Diagnosed With Stroke and ALS

2021

medicine.medical_specialtySensory stimulation therapyP300 event-related potentialbusiness.industryGeneral NeuroscienceCorrectionmedicine.diseasestrokeBCI performancelcsh:RC321-571locked-in syndromePhysical medicine and rehabilitationtactile stimulationmedicineLocked-in syndromeALSbusinessStrokelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBrain–computer interfaceNeuroscienceFrontiers in Neuroscience
researchProduct

Plasma cortisol levels in amyotrophic lateral sclerosis

2013

medicine.medical_specialtyEndocrinologyPlasma cortisolNeurologybusiness.industryInternal medicinemedicineNeurology (clinical)Amyotrophic lateral sclerosismedicine.diseasebusinessJournal of the Neurological Sciences
researchProduct

A novel compound heterozygous mutation in GALC associated with adult-onset Krabbe disease: case report and literature review

2021

Krabbe disease (KD) is a rare autosomal recessive lipid storage leukodystrophy. It is caused by deficient enzyme activity resulting from mutations of the β-galactocerebrosidase (GALC) gene. KD is distinguished into subtypes based on the age of onset; these are early infantile, late infantile, juvenile, and adult-onset. We report a case of a 47-year-old Caucasian man with a 2-year history of muscle atrophy and weakness in both hands associated with pyramidal signs and mild spasticity in the lower limbs. An extensive work-up led this motor neuron disease-like disorder to be diagnosed as adult-onset KD. The patient was found to be compound heterozygous for two GALC mutations (p.G286D and p.Y49…

MaleCellular and Molecular NeuroscienceHeterozygoteMutationGeneticsHumansSettore MED/26 - NeurologiaMiddle AgedGenetics (clinical)Compound heterozygous mutation GALC Adult-onset Krabbe disease Peripheral neuropathyGalactosylceramidaseLeukodystrophy Globoid Cell
researchProduct

Performance Differences Using a Vibro-Tactile P300 BCI in LIS-Patients Diagnosed With Stroke and ALS

2018

Patients with locked-in syndrome (LIS) are typically unable to move or communicate and can be misdiagnosed as patients with disorders of consciousness (DOC). Behavioral assessment scales are limited in their ability to detect signs of consciousness in this population. Recent research has shown that brain-computer interface (BCI) technology could supplement behavioral scales and allows to establish communication with these severely disabled patients. In this study, we compared the vibro-tactile P300 based BCI performance in two groups of patients with LIS of different etiologies: stroke (n = 6) and amyotrophic lateral sclerosis (ALS) (n = 9). Two vibro-tactile paradigms were administered to …

medicine.medical_specialtyPopulationDisorders of consciousnessWristAudiologylcsh:RC321-57103 medical and health scienceslocked-in syndrome0302 clinical medicinemedicine030212 general & internal medicineeducationStrokelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBrain–computer interfaceOriginal Researcheducation.field_of_studySensory stimulation therapyP300 event-related potentialbusiness.industryGeneral NeuroscienceCognitionmedicine.diseasestrokeBCI performancemedicine.anatomical_structuretactile stimulationLocked-in syndromeALSbusiness030217 neurology & neurosurgeryNeuroscienceFrontiers in Neuroscience
researchProduct

ALS-Related Mutant FUS Protein Is Mislocalized to Cytoplasm and Is Recruited into Stress Granules of Fibroblasts from Asymptomatic <b><i>…

2017

<b><i>Background:</i></b> Amyotrophic lateral sclerosis (ALS) shows a strong genetic basis, with <i>SOD1</i>, <i>FUS</i>, <i>TARDBP</i>, and <i>C9ORF72 </i>being the genes most frequently involved<i>. </i>This has allowed identification of asymptomatic mutation carriers, which may be of help in understanding the molecular changes preceding disease onset. <b><i>Objectives:</i></b> We studied the cellular expression of FUS protein and the effect of heat-shock- and dithiothreitol-induced stress in fibroblasts from <i>FUS</i> P525L mutation carriers, healthy controls, and pati…

0301 basic medicineBiologymedicine.diseaseSubcellular localizationTARDBPMolecular biology03 medical and health sciencesCell nucleus030104 developmental biology0302 clinical medicineStress granulemedicine.anatomical_structureNeurologyC9orf72CytoplasmmedicineNeurology (clinical)Amyotrophic lateral sclerosis030217 neurology & neurosurgeryRNA-Binding Protein FUSNeurodegenerative Diseases
researchProduct

Genome-wide Analyses Identify KIF5A as a Novel ALS Gene

2018

© 2018 Elsevier Inc.

MaleAls geneGenome-wide association studyFAMILIAL ALSALS; axonal transport; cargo; GWAS; KIF5A; WES; WGS0302 clinical medicine80 and overPsychologyGWASKIF5AAetiologycargoAged 80 and over0303 health sciencesFrench ALS ConsortiumKinesinKINESIN HEAVY-CHAINCognitive Sciencesaxonal transportHumanHereditary spastic paraplegiaNeuroscience(all)Single-nucleotide polymorphismTARGETED DISRUPTIONArticle03 medical and health sciencesGeneticsHumansAmino Acid SequenceLoss functionAgedHEXANUCLEOTIDE REPEATNeuroscience (all)MUTATIONSAmyotrophic Lateral Sclerosis3112 Neurosciences1702 Cognitive Sciencemedicine.diseaseITALSGEN ConsortiumAnswer ALS Foundation030104 developmental biologyALS Sequencing ConsortiumHuman medicine1109 Neurosciences030217 neurology & neurosurgery0301 basic medicineALS; GWAS; KIF5A; WES; WGS; axonal transport; cargo[SDV]Life Sciences [q-bio]KinesinsNeurodegenerativeGenetic analysisGenomeAMYOTROPHIC-LATERAL-SCLEROSIS3124 Neurology and psychiatryCohort StudiesPathogenesisLoss of Function MutationMissense mutation2.1 Biological and endogenous factorsAmyotrophic lateral sclerosisNYGC ALS ConsortiumGeneticsGeneral NeuroscienceALS axonal transport cargo GWAS KIF5A WES WGSMiddle AgedPhenotypeSettore MED/26 - NEUROLOGIANeurologicalProject MinE ALS Sequencing ConsortiumKinesinWESFemaleAdultBiologyGENOTYPE IMPUTATIONALS; axonal transport; cargo; GWAS; KIF5A; WES; WGS; Adult; Aged; Aged 80 and over; Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Cohort Studies; Female; Genome-Wide Association Study; Humans; Kinesin; Loss of Function Mutation; Male; Middle Aged; Young AdultNOYoung AdultRare DiseasesmedicineSLAGEN ConsortiumGene030304 developmental biologyClinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) ConsortiumNeurology & NeurosurgeryHuman GenomeNeurosciencesAXONAL-TRANSPORTBrain DisordersALS; axonal transport; cargo; GWAS; KIF5A; WES; WGS;Family memberDNA-DAMAGEMOTOR-NEURONS3111 BiomedicineCohort StudieALSGenomic Translation for ALS Care (GTAC) ConsortiumWGSAmyotrophic Lateral SclerosiGenome-Wide Association StudyALS; axonal transport; cargo; GWAS; KIF5A; WES; WGS; Neuroscience (all)
researchProduct

Early and rapidly progressing respiratory failure in a patient with amyotrophic lateral sclerosis: when FVC% is misleading

2018

Introduction Respiratory failure is the leading cause of death in amyotrophic lateral sclerosis (ALS) [1]. The involvement of respiratory function is a negative predictor of survival, which can be in part overcome by a prompt initiation of non-invasive mechanical ventilation (NIV). Seated forced vital capacity (FVC%) is a widely used measure to monitor respiratory function, and it is often taken as a surrogate outcome measure in clinical trials. However, it may be within a normal range in ALS patients with respiratory dysfunction [2]. Here we report on a case of an ALS patient with a rapidly evolving respiratory insufficiency, despite a rather normal FVC%. Case presentation The patient, a 6…

0301 basic medicineMalePediatricsmedicine.medical_specialtyNeurologyDermatologyDiagnosis Differential03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineFatal OutcomeMedicineAmyotrophic lateral sclerosisNeuroradiologyAgedbusiness.industryDisease progressionGeneral Medicinemedicine.diseasePsychiatry and Mental health030104 developmental biology030228 respiratory systemRespiratory failureDisease ProgressionNeurology (clinical)NeurosurgeryDifferential diagnosisbusinessRespiratory InsufficiencyAmyotrophic Lateral SclerosiHuman
researchProduct

Preserved somatosensory discrimination predicts consciousness recovery in unresponsive wakefulness syndrome

2017

Objective: To assess somatosensory discrimination and command following using a vibrotactile P300-based Brain-Computer Interface (BCI) in Unresponsive Wakefulness Syndrome (UWS), and investigate the predictive role of this cognitive process on the clinical outcomes.Methods: Thirteen UWS patients and six healthy controls each participated in two experimental runs in which they were instructed to count vibrotactile stimuli delivered to the left or right wrist. A BCI determined each subject's task performance based on EEG measures. All of the patients were followed up six months after the BCI assessment, and correlations analysis between accuracy rates and clinical outcome were investigated.Re…

MaleBrain-Computer InterfaceElectroencephalographyAudiologySomatosensory systemDiscrimination Psychological0302 clinical medicineMinimal consciousness (MCS)P300Persistent vegetative statemedia_commonAged 80 and overmedicine.diagnostic_test05 social sciencesWakefulneBrainElectroencephalographyCognitionMiddle AgedPrognosisSensory SystemsTouch PerceptionNeurologyBrain-Computer InterfacesConsciousness DisordersFemaleWakefulnessHumanAdultmedicine.medical_specialtyPrognosimedia_common.quotation_subject050105 experimental psychologyYoung Adult03 medical and health sciencesSomatosensory perceptionPhysiology (medical)medicineHumans0501 psychology and cognitive sciencesWakefulnessDisorders of consciousneAgedBrain–computer interfaceDiscrimination (Psychology)business.industryNeurophysiologymedicine.diseaseEvent-Related Potentials P300Consciousness DisorderUnresponsive wakefulness state (UWS)Neurology (clinical)Consciousnessbusiness030217 neurology & neurosurgeryClinical Neurophysiology
researchProduct

Prognostic Role of CSF β-amyloid 1–42/1–40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis

2021

The involvement of β-amyloid (Aβ) in the pathogenesis of amyotrophic lateral sclerosis (ALS) has been widely discussed and its role in the disease is still a matter of debate. Aβ accumulates in the cortex and the anterior horn neurons of ALS patients and seems to affect their survival. To clarify the role of cerebrospinal fluid (CSF) Aβ 1–42 and Aβ 42/40 ratios as a potential prognostic biomarker for ALS, we performed a retrospective observational study on a cohort of ALS patients who underwent a lumbar puncture at the time of the diagnosis. CSF Aβ 1–40 and Aβ 1–42 ratios were detected by chemiluminescence immunoassay and their values were correlated with clinical features. We found a signi…

Pathologymedicine.medical_specialtybeta amyloidArticlelcsh:RC321-571Pathogenesis03 medical and health sciences0302 clinical medicineCerebrospinal fluidmedicineAmyotrophic lateral sclerosislcsh:Neurosciences. Biological psychiatry. Neuropsychiatry030304 developmental biology0303 health sciencesMini–Mental State Examinationmedicine.diagnostic_testLumbar puncturebusiness.industryGeneral Neurosciencebiomarker.Retrospective cohort studymedicine.diseaseCortex (botany)Biomarker (medicine)biomarkerALSbusiness030217 neurology & neurosurgeryBrain Sciences
researchProduct

Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: effect on survival.

2010

Abstract Background Percutaneous endoscopic gastrostomy (PEG) is offered to amyotrophic lateral sclerosis (ALS) patients with severe dysphagia. Immediate benefits of PEG are adequate food intake and weight stabilization. However, the impact of PEG on survival is still uncertain. In this work we retrospectively evaluated the effect of PEG on survival in a cohort of ALS patients followed in a tertiary referral centre. Methods Between 2000 and 2007, 150 dysphagic ALS patients were followed until death or tracheostomy. PEG was placed in 76 patients who accepted the procedure and survival was analysed using the Kaplan–Meier life-table method. Results In ALS patients submitted to PEG, no major co…

MaleVital capacitymedicine.medical_specialtyPalliative caremedicine.medical_treatmentmacromolecular substancesEndoscopy GastrointestinalCohort StudiesPercutaneous endoscopic gastrostomyPEG ratiomedicineHumansAmyotrophic lateral sclerosisAgedRetrospective StudiesGastrostomybusiness.industryAmyotrophic Lateral Sclerosistechnology industry and agricultureRetrospective cohort studyMiddle Agedmedicine.diseaseDysphagiaSurgerySurvival RateTreatment OutcomeNeurologyFemaleNeurology (clinical)medicine.symptombusinessDeglutition DisordersCohort studyFollow-Up StudiesJournal of the neurological sciences
researchProduct

Autosomal dominant Brown–Vialetto–Van Laere syndrome with UBQLN1 mutation

2013

GeneticsNeurologyBrown–Vialetto–Van Laere syndromeMutation (genetic algorithm)medicineNeurology (clinical)Biologymedicine.diseaseJournal of the Neurological Sciences
researchProduct

Sleep-wake disturbances in patients with amyotrophic lateral sclerosis

2011

Objective To evaluate the frequency, severity and determinants of sleep disturbances in patients with amyotrophic lateral sclerosis (ALS). Methods Information about night-time complaints was collected using a standardised questionnaire, the Pittsburgh Sleep Quality Index (PSQI), and the Epworth Sleepiness Scale (ESS) in a group of 100 patients with ALS and in 100 control subjects matched for age and sex. Functional disability was assessed using the ALS Functional Rating Scale-Revised (ALSFRS-R). Sleep was studied by overnight polysomnography in 12 patients. Results Fifty-nine patients with ALS and 36 controls reported sleep disturbances. The mean global PSQI score of patients with ALS was s…

AdultMaleSleep Wake Disordersmedicine.medical_specialtyNeuromuscular diseasePolysomnographyPolysomnographySeverity of Illness IndexPittsburgh Sleep Quality IndexSurveys and QuestionnairesmedicineHumansNocturiaamyotrophic lateral sclerosis sleep disordersWakefulnessAmyotrophic lateral sclerosisDepression (differential diagnoses)Agedmedicine.diagnostic_testEpworth Sleepiness ScaleAmyotrophic Lateral SclerosisMiddle Agedmedicine.diseaseSleep in non-human animalsPsychiatry and Mental healthCase-Control StudiesPhysical therapyFemaleSurgeryNeurology (clinical)medicine.symptomSleepPsychologyJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Unilateral laryngeal and hypoglossal paralysis (Tapia's syndrome) in a patient with an inflammatory pseudotumor of the neck

2012

Tapia’s syndrome (TS) is a rare condition thought tobe causedby njury to the extracranial course of both recurrent laryngeal branch f the vagal nerve and hypoglossal nerve. First described in 1904, t occurs with unilateral paralysis of the vocal cord and tongue, ith normal function of the soft palate. Commonly reported causes re direct trauma, neurofibromatosis of X and XII nerves, carotid rtery dissection involving the ascending pharyngeal artery, and isplacement of endotracheal tube during general anesthesia [1].

AdultHypoglossal Nerve DiseasesGranuloma Plasma CellTongueTonguemedicine.arterymedicineParalysisHumansNeurofibromatosisNeurologic ExaminationSoft palateElectromyographybusiness.industryNeck tumors cranial nervesAscending pharyngeal arterySyndromeGeneral MedicineAnatomymedicine.diseaseMagnetic Resonance ImagingDissectionmedicine.anatomical_structureInflammatory pseudotumorFemaleSurgeryNeurology (clinical)Atrophymedicine.symptomTomography X-Ray ComputedbusinessVocal Cord ParalysisHypoglossal nerveNeckClinical Neurology and Neurosurgery
researchProduct

Causes and place of death in Italian patients with amyotrophic lateral sclerosis

2010

Objectives - To determine the causes and place of death in a cohort of Italian patients with amyotrophic lateral sclerosis (ALS). A better understanding of the likely causes of death in ALS might improve the palliative care at the end-of-life, whereas knowing the place of death will help to verify the need for highly specialized care services, e.g. hospice and nursing home. Patients and methods - Between 2000 and 2008, 182 ALS patients (onset: spinal, 127; bulbar, 55; M/F: 1.6) were followed in a single ALS Tertiary Centre in Palermo, Sicily, Italy until death. Medical data for each individual patient were recorded in a large database throughout the disease course. Information concerning ca…

medicine.medical_specialtyeducation.field_of_studyPalliative carebusiness.industryPopulationRetrospective cohort studyGeneral Medicinemedicine.diseaseSudden deathSurgeryNeurologyEmergency medicineCohortMedicineNeurology (clinical)Amyotrophic lateral sclerosisbusinesseducationCause of deathCohort studyActa Neurologica Scandinavica
researchProduct

Genetic investigation of amyotrophic lateral sclerosis patients in south Italy: a two-decade analysis

2020

Amyotrophic lateral sclerosis (ALS) is a multifactorial disease characterized by the interplay of genetic and environmental factors. In the majority of cases, ALS is sporadic, whereas familial forms occur in less than 10% of patients. Herein, we present the results of molecular analyses performed in a large cohort of Italian ALS patients, focusing on novel and already described variations in ALS-linked genes. Our analysis revealed that more than 10% of tested patients carried a mutation in one of the major ALS genes, with C9orf72 hexanucleotide expansion being the most common mutation. In addition, our study confirmed a significant association between ALS patients carrying the ATNX-1 interm…

Male0301 basic medicineSanger sequencingAgingTime FactorsDiseaseCohort Studies03 medical and health sciencessymbols.namesake0302 clinical medicineRisk FactorsC9orf72HumansMedicineAmyotrophic lateral sclerosisRisk factorGenePathologicalAtaxin-1Genetic Association StudiesAmyotrophic lateral sclerosiSanger sequencingGeneticsDNA Repeat ExpansionC9orf72 ProteinMolecular analysibusiness.industryMolecular analysisGeneral NeuroscienceGenetic VariationAmyotrophic lateral sclerosismedicine.disease030104 developmental biologyItalyMutation (genetic algorithm)symbolsFemaleNeurology (clinical)Geriatrics and Gerontologybusiness030217 neurology & neurosurgeryDevelopmental BiologyNeurobiology of Aging
researchProduct

Ethical issues: invasive ventilation in amyotrophic lateral sclerosis.

2012

The first man was a school headmaster. By his eye-gaze system he is able to order coins to enlarge his 10-year collection. His grandchildren extort presents from him in exchange for help. The second was a prefect and even now insists that the flowers in the garden represent the national flag. In spite of his gastrostomy, he still likes to sip his espresso from porcelain cups. The ventilation circuit 24/7 has not changed his custom to read the newspapers and listen to classical music in the living room. That girl is a young mum. She is fed by a tube, but she always makes her little child laugh with the dialectal phrases that she writes on the screen. The surgeon, every day in his electric wh…

medicine.medical_specialtymedia_common.quotation_subjectMedicine (miscellaneous)NewspaperWheelchairTracheostomySpite (sentiment)PhonemedicineHumansConversationGirlmedia_commonpalliative careEthical issuesOncology (nursing)business.industryAmyotrophic Lateral SclerosisGeneral MedicineRespiration ArtificialSurgeryClassical musicMedical–Surgical NursingAestheticsSettore MED/26 - NeurologiaALSbusinessBMJ supportivepalliative care
researchProduct

The Primitive Palmomental Reflex in Amyotrophic Lateral Sclerosis

2017

<b><i>Background and Purpose:</i></b> The palmomental reflex (PMR) is a primitive reflex that might be released due to inhibition in adulthood. It has been associated with several neurodegenerative conditions. The aim of the present study was to evaluate the frequency of PMR in amyotrophic lateral sclerosis (ALS). <b><i>Patients and Methods:</i></b> Non-demented ALS patients (<i>n</i> = 179) were recruited. Two groups of disease controls were enrolled: (a) non-demented patients with other neurological disorders (NC;<i> n</i> = 86, mean age 60 ± 14 years); (b) healthy subjects, healthy controls (HC; <i>n</i> …

AdultMale0301 basic medicinePrimitive reflexesmedicine.medical_specialtyGastroenterologyPalmomental reflex03 medical and health sciences0302 clinical medicineInternal medicinePrimitive reflexemedicineHumansPalmomental reflexAmyotrophic lateral sclerosisStrokeAmyotrophic lateral sclerosiAgedPyramidal tractsReflex Abnormalbusiness.industryAmyotrophic Lateral SclerosisMiddle Agedmedicine.disease030104 developmental biologymedicine.anatomical_structureIncreased riskNeurologyReflexFemalePyramidal tractNeurology (clinical)business030217 neurology & neurosurgeryThenar eminenceEuropean Neurology
researchProduct

Genomic portrait of a sporadic amyotrophic lateral sclerosis case in a large spinocerebellar ataxia type 1 family

2020

Background: Repeat expansions in the spinocerebellar ataxia type 1 (SCA1) gene ATXN1 increases the risk for amyotrophic lateral sclerosis (ALS), supporting a relationship between these disorders. We recently reported the co-existence, in a large SCA1 family, of a clinically definite ALS individual bearing an intermediate ATXN1 expansion and SCA1 patients with a full expansion, some of which manifested signs of lower motor neuron involvement. Methods: In this study, we employed a systems biology approach that integrated multiple genomic analyses of the ALS patient and some SCA1 family members. Results: Our analysis identified common and distinctive candidate genes/variants and related biolog…

Candidate geneSpinocerebellar Ataxia Type 1Medicine (miscellaneous)lcsh:MedicineNetworkBiologyArticle03 medical and health sciences0302 clinical medicinemulti-omics; networkC9orf72medicineCustomized aCGHAmyotrophic lateral sclerosisGene030304 developmental biologyTAF15Genetics0303 health sciencesMulti-omicslcsh:Rmedicine.diseaseAmyotrophic lateral sclerosisPhenotypeSCA1-MNNGSSpinocerebellar ataxiaSpinocerebellar ataxia030217 neurology & neurosurgeryPathway
researchProduct

Assessing Command-Following and Communication With Vibro-Tactile P300 Brain-Computer Interface Tools in Patients With Unresponsive Wakefulness Syndro…

2018

Persons diagnosed with disorders of consciousness (DOC) typically suffer from motor disablities, and thus assessing their spared cognitive abilities can be difficult. Recent research from several groups has shown that non-invasive brain-computer interface (BCI) technology can provide assessments of these patients' cognitive function that can supplement information provided through conventional behavioral assessment methods. In rare cases, BCIs may provide a binary communication mechanism. Here, we present results from a vibrotactile BCI assessment aiming at detecting command-following and communication in 12 unresponsive wakefulness syndrome (UWS) patients. Two different paradigms were admi…

0301 basic medicinemedicine.medical_specialtyevoked potentialsStimulus (physiology)WristElectroencephalographybrain computer interfacevegetative statelcsh:RC321-57103 medical and health sciences0302 clinical medicinePhysical medicine and rehabilitationmedicinevibro-tactile P300In patientlcsh:Neurosciences. Biological psychiatry. NeuropsychiatryOriginal ResearchBrain–computer interfaceunresponsive wakefulness syndromeevoked potentialmedicine.diagnostic_testbusiness.industrycommunicationGeneral NeuroscienceGrand averageCognition030104 developmental biologymedicine.anatomical_structureWakefulnessbusiness030217 neurology & neurosurgeryNeuroscienceFrontiers in Neuroscience
researchProduct

MARITAL STATUS IS A PROGNOSTIC FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS

2017

Background and objectives Several variables have been linked to a shorter survival in patients with amyotrophic lateral sclerosis (ALS), for example, female sex, older age, site of disease onset, rapid disease progression, and a relatively short diagnostic delay. With regard to marital status, previous studies suggested that living with a partner might be associated to a longer survival and a higher likelihood to proceed to tracheostomy. Therefore, to further strengthen this hypothesis, we investigated the role of marital status as a prognostic variable in a cohort of ALS patients. Methods We performed a retrospective analysis on 501 consecutive ALS patients for which a complete disease's n…

MaleGerontologyPrognostic variablemedicine.medical_specialtyDisease03 medical and health sciences0302 clinical medicineInternal medicineHumansMedicineAmyotrophic lateral sclerosisAgedRetrospective StudiesMarital Statusbusiness.industryProportional hazards modelAmyotrophic Lateral SclerosisALS - marital status - survivalGeneral MedicineMiddle AgedPrognosismedicine.diseaseNatural historyNeurology030220 oncology & carcinogenesisCohortRegression AnalysisMarital statusFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessBody mass index030217 neurology & neurosurgery
researchProduct

A rapidly progressive motor neuron disease associated to a natural killer cells leukaemia

2019

une system play a complex role, either protective or toxic, in ALS pathogenesis [1–3]. In particular, compelling evidence indicate that increased blood level of natural killer (NK) and NK-T cells may contribute to the disease development and progression [2,3]. Here, we report on a patient with an aggressive Motor Neuron Disease (MND) associated with NK/NK-T cells leukaemia. 1. Case report A 79-year-old man presented with several months-history of a progressive atrophy and weakness of the upper limbs, which quickly spread to the lower limbs. Onset was subtle and apparently occurred in the month of July (the specific date is not shown for privacy), when the patient noticed a mild weakness in …

Neurologybusiness.industryDisease progressionProgressive motor neuron diseaseLeukaemiaMedicineMotor neuron diseaseNeurology (clinical)NK-T cells.ParaneoplasticbusinessNeuroscienceJournal of the Neurological Sciences
researchProduct

Paraneoplastic motor neuron disease associated with breast cancer.

2014

Oncologymedicine.medical_specialtyAlsfrs rbusiness.industryCarcinoma Ductal BreastBreast NeoplasmsDiseaseMotor neuronMiddle Agedmedicine.diseasemedicine.anatomical_structureBreast cancerNeurologyInternal medicineMedicineHumansParaneoplastic PolyneuropathyFemaleNeurology (clinical)Motor Neuron DiseasebusinessClinical progressionEuropean journal of neurology
researchProduct

Bilateral Iatrogenic Femoral Neuropathy

2015

Dear Editor, Postoperative femoral neuropathy is an uncommon complication associated with pelvic/abdominal surgery. The main mechanism underlying this neuropathy is stretching and/or prolonged compression of the nerve.1,2 The nerve compression can be caused by the self-retaining retractors that are sometimes used during surgery directly constricting the nerve against the pelvic sidewall and inducing ischemia.1 Symptoms of femoral neuropathy are weakness of ipsilateral hip flexion and knee extension, and sensory deficit on the anteromedial thigh. The prognosis is generally good, with partial or complete recovery being common. Postoperative femoral neuropathy is generally unilateral2,3,4; bil…

medicine.medical_specialtybusiness.industryfemoral neuropathy - iatrogenic -HypoesthesiaThighmedicine.diseaseSurgeryRetractorLumbarPeripheral neuropathymedicine.anatomical_structureNeurologyFemoral nerveAnesthesiaMedicineSettore MED/26 - NeurologiaNeurology (clinical)Iliopsoasmedicine.symptombusinessLetter to the EditorAbdominal surgery
researchProduct

Reaching and grasping a glass of water by locked-in ALS patients through a BCI-controlled humanoid robot

2015

CommunicationNeurologybusiness.industryComputer scienceComputer visionNeurology (clinical)Artificial intelligencebusinessHumanoid robotBrain–computer interfaceJournal of the Neurological Sciences
researchProduct

Tracheostomy mechanical ventilation in patients with amyotrophic lateral sclerosis: Clinical features and survival analysis

2012

article i nfo Background: Tracheostomy mechanical ventilation (TMV) is performed in amyotrophic lateral sclerosis (ALS) patients with a respiratory failure or when the non-invasive ventilation (NIV) is no longer effective. We evaluated the clinical characteristics and survival of a cohort of tracheostomized ALS patients, followed in a single ALS Clinical Center. Methods: Between 2001 and 2010, 87 out of 279 ALS patients were submitted to TMV. Onset was spinal in 62 and bulbar in 25. After tracheostomy, most patients were followed up through telephone interviews to caregivers. A complete survival analysis could be performed in fifty-two TMV patients. Results: 31.3% ALS patients underwent tra…

Mechanical ventilationmedicine.medical_specialtyPalliative carebusiness.industrymedicine.medical_treatmentals tracheostomy survivalmedicine.diseaseSurgeryNeurologyRespiratory failureInterquartile rangeAnesthesiamedicineSettore MED/26 - NeurologiaNeurology (clinical)Age of onsetAmyotrophic lateral sclerosisbusinessProspective cohort studySurvival analysisJournal of the Neurological Sciences
researchProduct

PETECHIAL BRAIN HAEMORRHAGES IN ACUTE LYMPHOBLASTIC LEUKAEMIA.

2013

A 37-year-old office worker was referred to our hospital with severe weakness, malaise, headache and altered mental status. He was mildly febrile (37.5°C) with reported episodes of agitation. A blood count revealed 709 720 white blood cells (WBC) / μl with 33 000 platelets/μl. The clinical, imaging and laboratory workup led to a diagnosis of acute lymphoblastic leukaemia (ALL) …

Weaknessmedicine.medical_specialtyHematologybusiness.industryLymphoblastic leukemia brain haemorrhagesNeurooncologyBlood countGastroenterologyOffice workersSurgeryMalaisePsychiatry and Mental healthhemic and lymphatic diseasesInternal medicineMedicineLymphoblastic leukaemiaSurgeryPlateletNeurology (clinical)medicine.symptombusiness
researchProduct

Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in further phenotypic expans…

2019

Background Amyotrophic lateral sclerosis [1] is a genetically heterogeneous neurodegenerative disorder, characterized by late-onset degeneration of motor neurons leading to progressive limb and bulbar weakness, as well as of the respiratory muscles, which is the primary cause of disease fatality. To date, over 25 genes have been implicated as causative in ALS with C9orf72, SOD1, FUS, and TARDBP accounting for the majority of genetically positive cases. Results We identified two patients of Italian and French ancestry with a clinical diagnosis of juvenile-onset ALS who were mutation-negative in any of the known ALS causative genes. Starting with the index case, a consanguineous family of Ita…

MaleAmyotrophic lateral sclerosis ATP13A2 parkinsonismlcsh:Medicine0302 clinical medicineC9orf72Drug DiscoveryAmyotrophic lateral sclerosisIndex caseZebrafishExome sequencingMotor NeuronsGenetics0303 health sciencesDEMENTIA1184 Genetics developmental biology physiologyMiddle AgedPedigree3. Good healthProton-Translocating ATPasesPhenotypeMolecular MedicineFemaleSettore MED/26 - NeurologiaPrimary ResearchAdultlcsh:QH426-470SOD1BiologyTARDBP03 medical and health sciencesParkinsonian DisordersNeuronal Ceroid-LipofuscinosesExome SequencingGeneticsmedicineAnimalsHumansGenetic Predisposition to DiseaseMolecular Biology030304 developmental biologyGenetic heterogeneityAmyotrophic Lateral Sclerosislcsh:Rmedicine.diseaseDisease Models Animallcsh:GeneticsMutationNeuronal ceroid lipofuscinosis030217 neurology & neurosurgeryPARKINSONISM
researchProduct

The capacity to consent to treatment in amyotrophic lateral sclerosis: a preliminary report

2020

Background: Facing the relentless worsening of their condition, ALS patients are required to make decisions on treatments and end-of-life care. A cognitive impairment showed to be a negative prognostic factor in ALS patients, perhaps affecting the ability to make informed decisions. Notwithstanding its crucial role, the capacity to consent to treatment (CCT) has never been evaluated in these patients. Objectives: To assess the CCT in an ALS cohort in comparison to a control group, and to study the effects of demographic and clinical variables on this high-level cognitive function. Methods: 102 ALS patients and 106 healthy controls (HC) were enrolled. CCT was assessed using the MacArthur Com…

medicine.medical_specialtyNeurologygenetic structuresDiseaseNeuropsychological TestsAffect (psychology)03 medical and health sciencesCognition0302 clinical medicinemedicineHumans030212 general & internal medicineAmyotrophic lateral sclerosisAmyotrophic lateral sclerosiDepression (differential diagnoses)Informed Consentbusiness.industryAmyotrophic Lateral SclerosisNeuropsychologyCognitionmedicine.diseaseeye diseases3. Good healthCognitive impairmentNeurologyCohortNeuropsychological Testsense organsNeurology (clinical)Cognition Disordersbusiness030217 neurology & neurosurgeryDecision-makingHumanClinical psychologyJournal of Neurology
researchProduct

Tracheostomy mechanical ventilation in amyotrophic lateral sclerosis.

2013

Mechanical ventilationMalebusiness.industrymedicine.medical_treatmentAmyotrophic Lateral Sclerosismedicine.diseaseRespiration ArtificialTracheostomyNeurologyAnesthesiamedicineHumansFemaleNeurology (clinical)Amyotrophic lateral sclerosisbusinessRespiratory InsufficiencyJournal of the neurological sciences
researchProduct

A novel S379A TARDBP mutation associated to late-onset sporadic ALS

2019

Since 2008, several groups have reported a lot of dominant mutations in TARDBP gene as a primary cause of Amyotrophic lateral sclerosis (ALS). Mutations in TARDBP gene are responsible for 4–5% of familial ALS (fALS) and nearly 1% of sporadic ALS (sALS). To date, over 50 dominant mutations were found in TDP-43 in both familial and sporadic ALS patients, most of which were missense mutations in the C-terminal glycine-rich region. Herein, we describe the clinical and genetic analysis of an Italian non-familial ALS patient with a late onset and a rapid disease progression, which led to the discovery of a novel TARDBP mutation. After neurological evaluation, molecular investigation highlighted t…

TDP-43DNA-Binding ProteinMutation MissenseLate onsetDermatologyBiologymedicine.disease_causeGenetic analysisTARDBP03 medical and health sciencesExon0302 clinical medicinemedicineHumansMissense mutation030212 general & internal medicineAmyotrophic lateral sclerosisAge of OnsetTARDBPGeneticsAged 80 and overMutationAmyotrophic Lateral SclerosisGeneral Medicinemedicine.diseaseDNA-Binding ProteinsPsychiatry and Mental healthMutationFemaleNeurology (clinical)Age of onsetALS030217 neurology & neurosurgeryAmyotrophic Lateral SclerosiHuman
researchProduct

FUS mutations in sporadic amyotrophic lateral sclerosis

2011

Mutations in the FUS gene have recently been described as a cause of familial amyotrophic lateral sclerosis (ALS), but their role in the pathogenesis of sporadic ALS is unclear. We undertook mutational screening of all coding exons of FUS in 228 sporadic ALS cases, and, as previous reports suggest that exon 15 represents a mutational hotspot, we sequenced this exon in an additional 1295 sporadic cases. Six variants in six different cases were found, indicating that FUS mutations can underlie apparently sporadic ALS, but account for less than 1% of this form of disease. © 2010 .

AdultMaleAgingAmyotrophic lateral sclerosis; FUS; Italy; Sporadic disease; United States of America;AdolescentGenotypesporadic patientsDNA Mutational AnalysisALS; FUS mutations; sporadic patientsBiologymedicine.disease_causeArticlePathogenesisExonYoung AdultDNA Mutational AnalysisGenotypemedicineHumansFUS mutationsAmyotrophic lateral sclerosisChildGeneAgedGeneticsAged 80 and overMutationGeneral NeuroscienceAmyotrophic Lateral Sclerosisamyotrophic lateral sclerosis FUS geneticsExonsMiddle Agedmedicine.diseaseUnited StatesSettore MED/26 - NEUROLOGIAItalyMutationRNA-Binding Protein FUSFemaleNeurology (clinical)Geriatrics and GerontologyALSDevelopmental BiologyRNA-Binding Protein FUS
researchProduct

Plasma cortisol level in amyotrophic lateral sclerosis

2015

Background. Amyotrophic Lateral sclerosis (ALS) is associated with a significant distress, being linked to changes in hypothalamic-pituitary-adrenal axis activity. A loss of cortisol circadian rhythmicity in ALS patients was suggested, while more recently an increased plasma cortisol level in the disease has been reported. Objective. To assay the circadian plasma cortisol level in ALS and to study its relationship with the clinical phenotype and the rate of disease progression. Patients and methods. 135 ALS patients (Bulbar, 33; Spinal, 102; M/F = 1.73) and 110 controls (not affected by neurological or psychiatric disorders, free of drugs; M/F = 1.75) were recruited. Disease progression was…

Malemedicine.medical_specialtyNeurologyHydrocortisonemedicine.medical_treatmentCortisolInternal medicineALSFRS-RmedicineHumansCircadian rhythmAmyotrophic lateral sclerosisAgedHydrocortisoneMorningbusiness.industryAmyotrophic Lateral SclerosisBiomarkerMiddle Agedmedicine.diseaseCircadian RhythmSteroid hormoneEndocrinologyNeurologyDisease ProgressionBiomarker (medicine)FemaleNeurology (clinical)ALSbusinessBiomarkersmedicine.drugHormoneJournal of the Neurological Sciences
researchProduct

FACTORS AFFECTING THE DIAGNOSTIC DELAY IN AMYOTROPHIC LATERAL SCLEROSIS

2012

Abstract Background Although amyotrophic lateral sclerosis (ALS) is a relentlessly progressive disorder, early diagnosis allows a prompt start with the specific drug riluzole and an accurate palliative care planning. ALS at onset may however mimic several disorders, some of them treatable ( e.g. , multifocal motor neuropathy) or epidemiologically more frequent ( e.g. , cervical myelopathy). Objective To study the delay from onset to diagnosis in a cohort of ALS patients and to the variables that may affect it. Methods We performed a retrospective analysis of the diagnostic delays in a cohort of 260 patients affected by ALS (M/F = 1.32) followed at our tertiary referral ALS Center between 20…

Malemedicine.medical_specialtyPediatricsDelayed DiagnosisPalliative careALS diagnostic delay cognitive errorsCohort StudiesHumansMedicineAge of OnsetDiagnostic ErrorsAmyotrophic lateral sclerosisAgedRetrospective Studiesbusiness.industryAmyotrophic Lateral SclerosisRetrospective cohort studyGeneral MedicineMiddle Agedmedicine.diseaseMultivariate AnalysisCohortPhysical therapyFemaleSurgerySettore MED/26 - NeurologiaNeurology (clinical)Age of onsetDifferential diagnosisbusinessCohort studyMultifocal motor neuropathy
researchProduct

CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis

2017

Elevated cerebrospinal fluid (CSF), Neurofilament Light (NF-L) and phosphorylated Heavy (pNF-H) chain levels have been found in Amyotrophic Lateral Sclerosis (ALS), with studies reporting a correlation of both neurofilaments (NFs) with the disease progression. Here, we measured NF-L and pNF-H concentrations in the CSF of ALS patients from a single tertiary Center and investigated their relationship with disease-related variables. A total of 190 ALS patients (Bulbar, 29.9%; Spinal, 70.1%; M/F = 1.53) and 130 controls with mixed neurological diseases were recruited. Demographic and clinical variables were recorded, and Delta FS was used to rate the disease progression. Controls were divided i…

Male0301 basic medicineNeurologypNF-HNeurofilamentKaplan-Meier EstimateGastroenterology0302 clinical medicineCerebrospinal fluidNeurofilament ProteinsMedicinePhosphorylationAmyotrophic lateral sclerosisNeuroradiologyNeurofilament ProteinMiddle AgedPrognosisNeurologyArea Under CurveCohortDisease ProgressionFemaleHumanmedicine.medical_specialtyPrognostic variableNeurofilamentPrognosiCSFEnzyme-Linked Immunosorbent AssayFollow-Up StudieDiagnosis Differential03 medical and health sciencesOligoclonal BandInternal medicineHumansAgedInflammationbusiness.industryAmyotrophic Lateral SclerosisOligoclonal BandsBiomarkermedicine.disease030104 developmental biologyROC CurveNF-LNeurology (clinical)ALSDifferential diagnosisbusinessBiomarkers030217 neurology & neurosurgeryAmyotrophic Lateral SclerosiFollow-Up StudiesJournal of Neurology
researchProduct

Diabetic thoracic radiculopathy: a case of a young woman with clinical improvement following immunotherapy.

2020

Thoracic radiculopathy is a rare cause of thoracic-abdominal or abdominal pain in subjects with poorly controlled diabetes. We present a case of a young woman with type I diabetes and a severe abdominal pain in both lower quadrants. An extensive diagnostic gastroenterological and gynaecological workup did not disclose abnormalities. Electromyography revealed an initial polyneuropathy and significant neurogenic abnormalities in the T10-T12 paravertebral muscles. Following the hypothesis that the radiculopathy-related abdominal pain might have an immuno-mediated pathogenesis, the patient underwent a complex trial of immunotherapy, which was accompanied by a sustained improvement over months t…

0301 basic medicineAdultmedicine.medical_specialtyAbdominal painmedicine.medical_treatmentElectromyography030105 genetics & heredityThoracic VertebraePathogenesis03 medical and health sciences0302 clinical medicineFull recoveryRare DiseaseDiabetes mellitusmedicineHumansRadiculopathymedicine.diagnostic_testbusiness.industryElectromyographyMusclesImmunoglobulins IntravenousGeneral MedicineImmunotherapymedicine.diseaseSurgeryAbdominal PainDiabetes Mellitus Type 1Treatment OutcomeFemaleImmunotherapymedicine.symptombusinessPolyneuropathy030217 neurology & neurosurgeryDiabetic thoracic radiculopathyBMJ case reports
researchProduct

FUS MUTATIONS IN SPORADIC AMYOTROPHIC LATERAL SCLEROSIS: CLINICAL AND GENETIC ANALYSIS

2012

Fused in sarcoma (FUS) or translocation in liposarcoma (TLS), a DNA/RNA-binding protein, causes a dominant autosomal inherited form of amyotrophic lateral sclerosis (ALS), ALS 6. Its main role in neurodegeneration is highlighted by the presence of cytoplasmic accumulation of its mutant protein form in ALS patients. To further define the frequency and spectrum of FUS gene mutations, we have performed a molecular screening of a cohort of 327 Italian patients from Southern Italy with sporadic ALS (SALS). We identified 4 patients carrying 3 different missense mutations and several polymorphisms. Two different substitutions occurring in the same amino acidic position have been observed in 2 pati…

MaleAgingPopulationDNA Mutational AnalysisBiologyGene mutationmedicine.disease_causeGenetic analysisFUS geneMutant proteinALS; FUS gene; mutation; sporadicmedicineMissense mutationHumansGenetic Predisposition to DiseaseAmyotrophic lateral sclerosiseducationAgedGeneticsAged 80 and overNeurologic ExaminationMutationeducation.field_of_studyGeneral NeuroscienceNeurodegenerationAmyotrophic Lateral SclerosisExonsMiddle AgedALS; FUS gene; Mutation; Sporadicmedicine.diseaseMagnetic Resonance ImagingSettore BIO/18 - GeneticasporadicMutationRNA-Binding Protein FUSFemaleSettore MED/26 - NeurologiaNeurology (clinical)ALSGeriatrics and GerontologyDevelopmental Biology
researchProduct

Effects of Repeating a Tactile Brain-Computer Interface on Patients with Disorder of Consciousness: A Hint of Recovery?

2019

Brain-computer interface (BCI) has been emerging as an assessment tool for patients with disorder of consciousness (DOC). With the advantages of high time resolution, low cost and portable design, EEG based BCI systems are especially suitable for bedside measurement. Recent studies showed the successful application of an EEG based BCI on DOC assessment and communication. However, the effect of repeated BCI measurement on this patient group is not clear. In this study, a tactile BCI paradigm was repeated 12 runs for 10 consecutive days on 5 DOC patients. Although the BCI performance varied among runs and days, every patient reached at least once the accuracy above 60%. Moreover, the Coma Rec…

Comamedicine.medical_specialtymedicine.diagnostic_testbusiness.industryInterface (computing)media_common.quotation_subjectTime resolutionAudiologyElectroencephalographymedicinemedicine.symptomPatient groupConsciousnessbusinessmedia_commonBrain–computer interface2019 9th International IEEE/EMBS Conference on Neural Engineering (NER)
researchProduct

Response to the letter to the Editor: Comments on marital status is a prognostic factor in amyotrophic lateral sclerosis. Safiri S et al

2018

Oncologymedicine.medical_specialtyPrognostic factorLetter to the editorPrognosibusiness.industryAmyotrophic Lateral SclerosisMEDLINEMarital StatuGeneral Medicinemedicine.disease03 medical and health sciences0302 clinical medicineNeurologyInternal medicinemedicineMarital status030212 general & internal medicineNeurology (clinical)Amyotrophic lateral sclerosisbusiness030217 neurology & neurosurgeryHumanActa Neurologica Scandinavica
researchProduct

Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis

2020

BACKGROUND AND PURPOSE To test the hypothesis that total tau (tTau), tau phosphorylated at threonine 181 (pTau) and pTau/tTau ratio in the cerebrospinal fluid (CSF) are diagnostic and prognostic biomarkers of amyotrophic lateral sclerosis (ALS), we performed a retrospective observational study in a large cohort of ALS patients and controls. METHODS We enrolled 196 ALS patients and 91 controls, who included patients with ALS-mimicking diseases and those with non-neurodegenerative diseases. All patients underwent lumbar puncture for CSF analysis at the time of the diagnostic evaluation or to first referral. We measured tTau and pTau levels in the CSF by chemiluminescence enzyme immunoassay. R…

medicine.medical_specialtyTau proteintau ProteinsGastroenterology03 medical and health sciences0302 clinical medicineCerebrospinal fluidInternal medicineHumansMedicine030212 general & internal medicineAmyotrophic lateral sclerosisALS biomarker CSF Taubiologybusiness.industryAmyotrophic Lateral SclerosisArea under the curveRetrospective cohort studyPrognosismedicine.diseaseConfidence intervalROC CurveNeurologybiology.proteinBiomarker (medicine)Neurology (clinical)Age of onsetbusinessBiomarkers030217 neurology & neurosurgeryEuropean Journal of Neurology
researchProduct

Incidence of amyotrophic lateral sclerosis in Sicily: A population based study

2012

Our objective was to investigate incidence of amyotrophic lateral sclerosis (ALS) in Sicily, southern Italy, by means of a population based study. We included people with ALS resident in fi ve Sicilian provinces, whose onset occurred in the two-year period 2005 2006 (population at 31 December 2006: 3,481,096 inhabitants). A multisource case-fi nding procedure was adopted and patients were classifi ed as affected by ALS according to revised El Escorial criteria. During the two-year surveillance period, 97 patients meeting eligibility criteria included 57 males (58.8%) and 40 females (41.2%). Crude annual incidence rate was 1.4/100,000 person years (95% CI 1.33 1.47). The incidence rate was h…

AdultMaleGerontologymedicine.medical_specialtyAdolescentPopulationPrevalenceYoung AdultAge DistributionEpidemiologymedicineHumanssicilyamyotrophic lateral sclerosiYoung adultAmyotrophic lateral sclerosisChildeducationAgedAged 80 and overSex Characteristicseducation.field_of_studybusiness.industryIncidence (epidemiology)Amyotrophic Lateral SclerosisInfantGeneral MedicineMiddle Agedmedicine.diseasepopulation-basedPopulation based studyItalyNeurologyamyotrophic lateral sclerosis; incidence; epidemiology; population-based; sicilyChild PreschoolincidenceFemaleepidemiologySettore MED/26 - NeurologiaNeurology (clinical)businessDemographySex characteristicsAmyotrophic Lateral Sclerosis
researchProduct

Long-Lasting Cranial Nerve III Palsy as a Presenting Feature of Chronic Inflammatory Demyelinating Polyneuropathy

2015

We describe a patient with chronic inflammatory demyelinating polyneuropathy (CIDP) in which an adduction deficit and ptosis in the left eye presented several years before the polyneuropathy. A 52-year-old man presented with a 14-year history of unremitting diplopia, adduction deficit, and ptosis in the left eye. At the age of 45 a mild bilateral foot drop and impaired sensation in the four limbs appeared, with these symptoms showing a progressive course. The diagnostic workup included EMG/ENG which demonstrated reduced conduction velocity with bilateral and symmetrical sensory and motor involvement. Cerebrospinal fluid studies revealed a cytoalbuminologic dissociation. A prolonged treatmen…

Diplopiamedicine.medical_specialtyWeaknessbusiness.industrylcsh:Rlcsh:MedicineCase ReportChronic inflammatory demyelinating polyneuropathyGeneral Medicinemedicine.diseaseNerve conduction velocitySurgeryCerebrospinal fluidPtosisSensationmedicineSettore MED/26 - Neurologiamedicine.symptombusinessPolyneuropathypolyneuropathy CIDP cranial nervesCase Reports in Medicine
researchProduct

MindBEAGLE — A new system for the assessment and communication with patients with disorders of consciousness and complete locked-in syndrom

2017

Patients with disorders of consciousness (DOC) cannot reply to questions or clinical assessments using voluntary motor control, and therefore it is very difficult to assess their cognitive capabilities and conscious awareness. Patients who are locked-in (LIS) are instead fully conscious, and they can communicate with their preserved eye movements. However, when the residual oculomotor activity is also lost (e.g., patients with amyotrophic lateral sclerosis disease of very long duration), the locked-in status becomes complete (CLIS). In CLIS patients, detection of conscious awareness may become very challenging, similarly to the subjects with DOC. mindBEAGLE has a physiological testing batte…

medicine.medical_specialtymedicine.diagnostic_testbusiness.industry05 social sciencesEye movementMotor controlDisorders of consciousnessCognitionElectroencephalographyAudiologymedicine.disease050105 experimental psychology03 medical and health sciences0302 clinical medicineMotor imagerymedicine0501 psychology and cognitive sciencesLocked-in syndromebusiness030217 neurology & neurosurgeryBrain–computer interface2017 IEEE International Conference on Systems, Man, and Cybernetics (SMC)
researchProduct

Ataxin-1 and ataxin-2 intermediate-length PolyQ expansions in amyotrophic lateral sclerosis.

2012

ABSTRACT Objective: Recent evidence suggests that intermediate-length polyglutamine (PolyQ) expansions in the ataxin-2 ( ATXN-2 ) gene are a risk factor for amyotrophic lateral sclerosis (ALS). This work was undertaken with the aim to investigate the frequency of ataxin-1 ( ATXN-1 ) and ATXN-2 PolyQ expansions in a cohort of patients with sporadic ALS (sALS) and patients with familial ALS (fALS) from southern Italy. Methods: We assessed the PolyQ lengths of ATXN-1 and ATXN-2 in 405 patients with sALS, 13 patients with fALS, and 296 unrelated controls without history of neurodegenerative disorders. Results: We found significantly higher intermediate PolyQ expansions ≥32 for ATXN-1 alleles an…

OncologyAdultMalemedicine.medical_specialtyGenotypeALS; ATXN-1; ATXN-2Ataxin 1Nerve Tissue ProteinsRisk FactorsInternal medicinemedicineHumansIn patientGenetic Predisposition to DiseaseAmyotrophic lateral sclerosisAlleleRisk factorAge of OnsetATXN-2ATXN-1AllelesAtaxin-1AgedAged 80 and overbiologybusiness.industryAmyotrophic Lateral SclerosisAge FactorsNuclear ProteinsMiddle Agedmedicine.diseaseIncreased riskPOLYGLUTAMINE EXPANSIONS; HEXANUCLEOTIDE REPEAT; ALS; TYPE-1; NEURODEGENERATION; PHENOTYPE; GENETICS; PROTEIN; C9ORF72; RISKAtaxinsItalyAtaxinCohortbiology.proteinFemaleSettore MED/26 - NeurologiaNeurology (clinical)ALSbusinessPeptidesTrinucleotide Repeat Expansion
researchProduct

The eye-tracking computer device for communication in amyotrophic lateral sclerosis

2013

Objective To explore the effectiveness of communication and the variables affecting the eye-tracking computer system (ETCS) utilization in patients with late-stage amyotrophic lateral sclerosis (ALS). Methods We performed a telephone survey on 30 patients with advanced non-demented ALS that were provisioned an ECTS device. Median age at interview was 55 years (IQR = 48–62), with a relatively high education (13 years, IQR = 8–13). A one-off interview was made and answers were later provided with the help of the caregiver. The interview included items about demographic and clinical variables affecting the daily ETCS utilization. Results The median time of ETCS device possession was 15 months …

AdultMalemedicine.medical_specialtyClinical variablesEye MovementsCommunication Aids for DisabledPhysical medicine and rehabilitationmedicineHumansIn patientAmyotrophic lateral sclerosisComputer devicebusiness.industryData CollectionAmyotrophic Lateral SclerosisEye movementHigh educationGeneral MedicineMiddle Agedmedicine.diseaseCaregiversNeurologyMedian timeBrain-Computer InterfacesCommunication DisordersPhysical therapyEye trackingFemaleNeurology (clinical)businessActa Neurologica Scandinavica
researchProduct

A Human-Humanoid Interaction Through the Use of BCI for Locked-In ALS Patients Using Neuro-Biological Feedback Fusion.

2018

This paper illustrates a new architecture for a human–humanoid interaction based on EEG-brain computer interface (EEG-BCI) for patients affected by locked-in syndrome caused by Amyotrophic Lateral Sclerosis (ALS). The proposed architecture is able to recognise users’ mental state accordingly to the biofeedback factor $\text {B}_{\text f}$ , based on users’ attention, intention, and focus, that is used to elicit a robot to perform customised behaviours. Experiments have been conducted with a population of eight subjects: four ALS patients in a near locked-in status with normal ocular movement and four healthy control subjects enrolled for age, education, and computer expertise. The results s…

MaleEye MovementsBCI Locked-In Patients ALS Patients Human-Humanoid Robot Interaction neuro-biological feedback fusionmedicine.medical_treatment02 engineering and technology0302 clinical medicineAttentionBCIAmyotrophic lateral sclerosiseducation.field_of_studyGeneral NeuroscienceRehabilitationlocked-in patientsRoboticsElectroencephalographyRoboticsHealthy VolunteersBrain-Computer InterfacesFemalePsychologyHumanoid robotAlgorithmsAdultmedicine.medical_specialty0206 medical engineeringPopulationhuman-humanoid robot interactionBiomedical EngineeringBiofeedbackProsthesis DesignQuadriplegia03 medical and health sciencesPhysical medicine and rehabilitationEvent-related potentialInternal MedicinemedicineHumanseducationBrain–computer interfacebusiness.industryAmyotrophic Lateral SclerosisEye movementBiofeedback Psychologymedicine.disease020601 biomedical engineeringEvent-Related Potentials P300neuro-biological feedback fusionALS patientsArtificial intelligencebusiness030217 neurology & neurosurgeryPsychomotor PerformanceIEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society
researchProduct

VARIABILI GENETICHE, BIOLOGICHE E CLINICHE COME FATTORI PROGNOSTICI DI PROGRESSIONE E SOPRAVVIVENZA NELLA SCLEROSI LATERALE AMIOTROFICA

2014

Questo studio ha riguardato l'analisi di alcune variabili prognostiche e di sopravvivenza nella sclerosi laterale amiotrofica, con particolare riferimento alla caratterizzazione di nuovi geni ed al ruolo di interventi di management.

SCLEROSI LATERALE AMIOTROFICAFATTORI PROGNOSTICI DI SOPRAVVIVENZASettore MED/26 - NeurologiaVARIABILITA' FENOTIPICA
researchProduct

Reaching and Grasping a Glass of Water by Locked-In ALS Patients through a BCI-Controlled Humanoid Robot

2017

Locked-in Amyotrophic Lateral Sclerosis (ALS) patients are fully dependent on caregivers for any daily need. At this stage, basic communication and environmental control may not be possible even with commonly used augmentative and alternative communication devices. Brain Computer Interface (BCI) technology allows users to modulate brain activity for communication and control of machines and devices, without requiring a motor control. In the last several years, numerous articles have described how persons with ALS could effectively use BCIs for different goals, usually spelling. In the present study, locked-in ALS patients used a BCI system to directly control the humanoid robot NAO (Aldebar…

medicine.medical_specialtyamyotrophic lateral sclerosisBrain activity and meditation0206 medical engineering02 engineering and technologybrain computer interfaceTask (project management)03 medical and health sciencesBehavioral Neurosciencelocked-in syndrome0302 clinical medicineHuman–computer interactionmedicineAmyotrophic lateral sclerosiBiological PsychiatryBrain–computer interfaceOriginal Researchhumanoid robotbusiness.industryMotor controlRoboticsenvironmental control020601 biomedical engineeringAugmentative and alternative communicationNeuropsychology and Physiological PsychologyNeurologyPsychiatry and Mental HealthPhysical therapyRobotArtificial intelligencebusinessPsychology030217 neurology & neurosurgeryHumanoid robotNeuroscienceFrontiers in Human Neuroscience
researchProduct

THE COGNITIVE AND BEHAVIOURAL IMPAIRMENT IN AMYOTROPHIC LATERAL SCLEROSIS

2008

ALS - Cognitive impairment
researchProduct

PERCUTANEOUS ENDOSCOPIC GASTROSTOMY (PEG) IMPROVES SURVIVAL IN AMYOTROPHIC LATERAL SCLEROSIS

2008

SLAPEG
researchProduct

Additional file 1: of Mutations in ATP13A2 (PARK9) are associated with an amyotrophic lateral sclerosis-like phenotype, implicating this locus in fur…

2019

Figure S1. a Schematic of the endogenous zebrafish atp13a2 ortholog. The exons are shown are rectangles and the introns as horizontal lines. The splice junctions targeted with antisense morpholino oligonucleotides (atp13a2_3x4_SB and atp13a2_3x6_SB) are shown with red asterisks. b Gel images showing the efficiency of the atp13a2_3x4_SB and atp13a2_3x6_SB morpholinos. The first lane in each gel photograph shows amplicons from the respective loci flanking the targeted sequences, with no aberrations observed. In the embryos injected with morpholino oligonucleotides, aberrant bands were evident, showing that the morpholinos were efficient in knocking down the expression of endogenous atp13a2. F…

animal structuresembryonic structures
researchProduct

RESTLESS LEGS SYNDROME IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: A CASE-CONTROL STUDY.

2008

Rls - Als
researchProduct

HFE p.H63D polymorphism does not influence ALS phenotype and survival.

2015

It has been recently reported that the p.His63Asp polymorphism of the HFE gene accelerates disease progression both in the SOD1 transgenic mouse and in amyotrophic lateral sclerosis (ALS) patients. We have evaluated the effect of HFE p.His63Asp polymorphism on the phenotype in 1351 Italian ALS patients (232 of Sardinian ancestry). Patients were genotyped for the HFE p.His63Asp polymorphism (CC, GC, and GG). All patients were also assessed for C9ORF72, TARDBP, SOD1, and FUS mutations. Of the 1351 ALS patients, 363 (29.2%) were heterozygous (GC) for the p.His63Asp polymorphism and 30 (2.2%) were homozygous for the minor allele (GG). Patients with CC, GC, and GG polymorphisms did not significa…

MaleAgingSurvivalSettore MED/03 - GENETICA MEDICAMiceSuperoxide Dismutase-1C9orf72HFE polymorphismAmyotrophic lateral sclerosisAmyotrophic lateral sclerosis; HFE polymorphisms; Phenotype; SOD1; Survival; Aged; Alleles; Amyotrophic Lateral Sclerosis; Animals; Disease Progression; Female; Hemochromatosis Protein; Histocompatibility Antigens Class I; Humans; Italy; Male; Membrane Proteins; Mice; Middle Aged; Polymorphism Genetic; Superoxide Dismutase; Superoxide Dismutase-1; Survival Rate; Genetic Association Studies; PhenotypeHFE polymorphismsMembrane ProteinAlleleAmyotrophic lateral sclerosis; HFE polymorphisms; Phenotype; SOD1; Survival; Neurology (clinical); Neuroscience (all); Aging; Developmental Biology; Geriatrics and GerontologyGeneral NeuroscienceSOD1Middle AgedPhenotypeSurvival RatePhenotypeItalyAmyotrophic lateral sclerosis; HFE polymorphisms; SOD1; phenotype; survivalDisease ProgressionFemaleHumanmedicine.medical_specialtySOD1Amyotrophic lateral sclerosis; HFE polymorphisms; Phenotype; SOD1; Survival;Genetic Association StudieBiologyTARDBPArticleGeneticInternal medicinemedicineAnimalsHumansAllelePolymorphismHemochromatosis ProteinSurvival rateAmyotrophic lateral sclerosiAllelesGenetic Association StudiesAgedNeuroscience (all)Polymorphism GeneticAnimalSuperoxide DismutaseAmyotrophic Lateral SclerosisHistocompatibility Antigens Class Inutritional and metabolic diseasesMembrane Proteinsmedicine.diseaseMinor allele frequencyEndocrinologyImmunologyNeurology (clinical)Geriatrics and GerontologyDevelopmental BiologyNeurobiology of aging
researchProduct

Prevalenza di Osteoporosi e Osteopenia in una popolazione adulto-anziana: Zabut Aging Project

2004

researchProduct

Causes and place of death in Italian patients with amyotrophic lateral sclerosis

2010

Objectives - To determine the causes and place of death in a cohort of Italian patients with amyotrophic lateral sclerosis (ALS). A better understanding of the likely causes of death in ALS might improve the palliative care at the end-of-life, whereas knowing the place of death will help to verify the need for highly specialized care services, e.g. hospice and nursing home. Patients and methods - Between 2000 and 2008, 182 ALS patients (onset: spinal, 127; bulbar, 55; M/F: 1.6) were followed in a single ALS Tertiary Centre in Palermo, Sicily, Italy until death. Medical data for each individual patient were recorded in a large database throughout the disease course. Information concerning ca…

MaleDATABASEUNITED-STATESKaplan-Meier EstimateCohort StudiesResidence CharacteristicsCause of DeathHumansEPIDEMIOLOGYPOPULATIONAgedRetrospective StudiesChi-Square DistributionAmyotrophic Lateral SclerosisNATURAL-HISTORYMiddle AgedCAREALS death epidemiologyLIFEdeathsItalyENDSURVIVALSettore MED/26 - NeurologiaFemaleALSRespiratory Insufficiency
researchProduct

Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis

2011

Background: Percutaneous endoscopic gastrostomy (PEG) is offered to amyotrophic lateral sclerosis (ALS) patients with severe dysphagia. Immediate benefits of PEG are adequate food intake and weight stabilization. However, the impact of PEG on survival is still uncertain. In this work we retrospectively evaluated the effect of PEG on survival in a cohort of ALS patients followed in a tertiary referral centre. Methods: Between 2000 and 2007, 150 dysphagic ALS patients were followed until death or tracheostomy. PEG was placed in 76 patients who accepted the procedure and survival was analysed using the Kaplan-Meier life-table method. Results: In ALS patients submitted to PEG, no major complica…

Settore MED/26 - NeurologiaAmyotrophic lateral sclerosis dysphagia PEG respiratory impairment survival
researchProduct

Cognitive Impairment and Osteoporosis in persons 50+ years old: a population-based study.

2004

researchProduct

Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS

2010

Summary Using exome sequencing, we identified a p.R191Q amino acid change in the valosin-containing protein ( VCP ) gene in an Italian family with autosomal dominantly inherited amyotrophic lateral sclerosis (ALS). Mutations in VCP have previously been identified in families with Inclusion Body Myopathy, Paget disease, and Frontotemporal Dementia (IBMPFD). Screening of VCP in a cohort of 210 familial ALS cases and 78 autopsy-proven ALS cases identified four additional mutations including a p.R155H mutation in a pathologically proven case of ALS. VCP protein is essential for maturation of ubiquitin-containing autophagosomes, and mutant VCP toxicity is partially mediated through its effect on…

Adenosine TriphosphataseMaleCell Cycle ProteinsUBQLN2Cohort Studies0302 clinical medicineReference ValuesValosin Containing ProteinCell Cycle ProteinReference ValueAmyotrophic lateral sclerosisExome sequencingAdenosine TriphosphatasesGenetics0303 health sciencesGeneral NeuroscienceExonsMiddle AgedPedigree3. Good healthMultisystem proteinopathyFemaleSettore MED/26 - NeurologiaCase-Control StudieChromosomes Human Pair 9HumanFrontotemporal dementiaNeuroscience(all)Valosin-containing proteinExonBiologyProtein degradationTARDBPArticle03 medical and health sciencesmedicineHumansAged030304 developmental biologyAmyotrophic lateral sclerosis familial ALS exome sequencingNeuroscience (all)business.industryAmyotrophic Lateral Sclerosismedicine.diseaseAmino Acid SubstitutionCase-Control StudiesMutationbiology.proteinCohort Studiebusiness030217 neurology & neurosurgeryAmyotrophic Lateral SclerosiNeuron
researchProduct

The role of ethical attitudes in the mortality of patients with disorders of consciousness.

2022

NeurologyAttitudeConsciousnessConsciousness DisordersHumansSettore MED/26 - Neurologiaethical attitudeNeurology (clinical)DOCmortalityEuropean journal of neurologyREFERENCES
researchProduct

MTHFR C677T allelic variant is not associated to plasma and cerebrospinal fluid homocysteine in amyotrophic lateral sclerosis

2014

Amiotrophic lateral sclerosis (ALS) is a neurological disorder with a multifactorial etiopathogenesis including excitotoxicity, intracellular calcium increase and mitochondrial damage together with oxidative stress and apoptosis. Overall, the relationship between homocysteine (Hcy), motoneuron death and ALS appears to be complex and still under investigation. It has been already shown that Hcy is elevated in plasma and cerebrospinal fluid (CSF) of ALS patients, although mechanisms of hyperhomocysteinemia have not been elucidated yet. MTHFR C677T variant is the most common genetic determinant of increased homocysteinemia, but no studies regarding the effect of this polymorphism in ALS patien…

Malemedicine.medical_specialtyHomocysteineGenotypeClinical Biochemistrychemistry.chemical_compoundCerebrospinal fluidInternal medicineGenotypeMedicineMthfr c677tHumansamyotrophic lateral sclerosiAlleleAmyotrophic lateral sclerosismethylenetetrahydrofolate reductase (MTHFR)AllelesMethylenetetrahydrofolate Reductase (NADPH2)Cerebrospinal Fluidbiologybusiness.industryBiochemistry (medical)Amyotrophic Lateral SclerosisGenetic VariationGeneral MedicinehomocysteineMiddle Agedmedicine.diseaseEndocrinologychemistryMethylenetetrahydrofolate reductaseMTHFRbiology.proteinFemalebusiness
researchProduct

Risk factors for cognitive impairment in subjects with Behçet's disease

2004

In the present study we evaluated the prevalence and risk factors for cognitive impairment in subjects with Behçet's Disease (BD). The following risk factors were studied: age, education, disease duration, activity of disease, prednisone dosage, and anxiety and depression levels. Twenty-six BD out-patients without overt neurological involvement and 26 sex-matched controls completed a comprehensive neuropsychological battery. Compared to controls, BD subjects were significantly impaired on tasks evaluating long-term verbal and nonverbal memory, and visuospatial skills. Cognitive impairment was evident in 46.1% of BD patients compared with none of control subjects (p<.0001), with memory repr…

Cognitive impairmentNeuropsychologyMedicine (all)CorticosteroidSettore MED/26 - NeurologiaDisease activityBehcet's disease
researchProduct

How brain-computer interface technology may improve the diagnosis of the disorders of consciousness: A comparative study

2022

ObjectiveClinical assessment of consciousness relies on behavioural assessments, which have several limitations. Hence, disorder of consciousness (DOC) patients are often misdiagnosed. In this work, we aimed to compare the repetitive assessment of consciousness performed with a clinical behavioural and a Brain-Computer Interface (BCI) approach.Materials and methodsFor 7 weeks, sixteen DOC patients participated in weekly evaluations using both the Coma Recovery Scale-Revised (CRS-R) and a vibrotactile P300 BCI paradigm. To use the BCI, patients had to perform an active mental task that required detecting specific stimuli while ignoring other stimuli. We analysed the reliability and the effic…

minimally conscious stateunresponsive wakefulness syndromecovert consciousneComa Recovery Scale-RevisedGeneral Neurosciencebrain-computer interfacevegetative stateFrontiers in Neuroscience
researchProduct